Some info! - Revenue for the quarter fell by 39.3% to RM62.16mil from RM102.4mil previously as a result of a lower contribution from large-scale solar (LSS) segments as most projects were completed Notably reminder! - Prediction are base on previous harmonic patent - 6's new price point suggested
Some notes! - September 2020 TDM Berhad had RM512.9m of debt, an increase on RM461.2m, over one year. However, it also had RM181.8m in cash, and so its net debt is RM331.1m. Notably reminder. - By using Harmonic analysis suggested the price will move downtrend - New suggest 5's price point (in graph) as reference prediction of next swing.
Some infos! - NEW ISSUE OF SECURITIES issuance on 27 November, 2020. - Started develop & trial test covid vaccine! Some noted! - Kanger, Sinopharm inks agreement for Covid-19 vaccine distribution in Malaysia - Ho Wah Genting partners Xinkexian to produce Covid-19 vaccine
Some infos! For December, they expect all five lines to be operating. Due to the volume increase and higher average selling price (ASP), they expect 4Q20 earnings to be much better quarter-on-quarter. Notably reminder! - Seek for BUY area if breakout accomplish in next swing - Try not to hold too long.
Some infos! - As at 30 April 2020, the Group’s share price closed at RM0.32 with a total market capitalisation of RM99.20 million. For the sixteen months period ended 30 April 2020, our share’s highest and lowest closing price stood at RM0.570 and RM0.205 respectively, with average daily trading volume of approximately 104,701 units. Notably reminder! - hopefully...
Some news onward! Bintai Kinden Corp Bhd’s shares rose marginally in early trade Friday after its partner signed an agreement to to develop and commercialise a coronavirus vaccine in China. The counter added one sen to 72.5 sen with 20 million shares done. Bintai Kinden’s partner Generex Biotechnology Corporation has entered a framework agreement with Chinese...
Close below expected price target. :(
As expected, today price close above expected TP line
Fail:- - Are revenue and earnings forecast to grow? -Earnings have declined by 50.1% per year over past 5 years - Is their share price liquid and stable? Highly volatile share price over the past 3 months Pass:- - Are they forecast to achieve profitability? Whilst currently unprofitable, they have been profitable on average for the past 5 years - Are they in a...
Latest Share Price and Events - Stable Share Price : OPCOM is not significantly more volatile than the rest of MY stocks over the past 3 months, typically moving +/- 6% a week. - Volatility Over Time : OPCOM's weekly volatility has decreased from 13% to 6% over the past year. Mention! - TP will be difficult. Can count on range 0.445 ~ 0.565 neither! - Any SL...
While that might be a setback, it doesn't negate the nice returns received over the last twelve months. To wit, it had solidly beat the market, up 79%. Notably mention! Safe Zone:- - TP/Buy.UP areas in between 0.305 til 0.335 -SL not lower than 0.285
It is recorded as:- Share Price vs. Fair Value - 95.6% - below fair value by more than 20%. Notably reminder:- -TP - impulsive increase at 2.6, 2.7, 2.76 -SL - reverse condition no lower than 2.05
Take note" - TP's area at 1.3 upto 1.57 (70%) - SL area should be other than below 0.6
Take note at point! TP - 0.14, 0.15, 0.16 SL - each lower other than support line
After long period of sideways price movement, the motion increasingly by +46.7% Notably reminder! suggestion:- - TP will be short - SL setpoint will be below 0.5
How has Malpac Holdings Berhad performed over the past 5 years? - Yes, but slow growth about 8.2% Historical annual earnings growth? - Quality Earnings: MALPAC is currently unprofitable. - Growing Profit Margin: MALPAC is currently unprofitable. - Earnings Trend: MALPAC is unprofitable, but has reduced losses over the past 5 years at a rate of 8.2% per year. -...